Douglas E Williams - Net Worth and Insider Trading

Douglas E Williams Net Worth

The estimated net worth of Douglas E Williams is at least $2 Million dollars as of 2024-04-25. Douglas E Williams is the EVP Research & Development of Biogen Inc and owns about 11,817 shares of Biogen Inc (BIIB) stock worth over $2 Million. Douglas E Williams is the Director of Ovid Therapeutics Inc and owns about 5,000 shares of Ovid Therapeutics Inc (OVID) stock worth over $15,750. Douglas E Williams is also the President & CEO of Codiak BioSciences Inc and owns about 7,655 shares of Codiak BioSciences Inc (CDAKQ) stock worth over $12. Details can be seen in Douglas E Williams's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Douglas E Williams has not made any transactions after 2023-03-28 and currently still holds the listed stock(s).

Transaction Summary of Douglas E Williams

To

Douglas E Williams Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Douglas E Williams owns 9 companies in total, including Codiak BioSciences Inc (CDAKQ) , Ovid Therapeutics Inc (OVID) , and Ironwood Pharmaceuticals Inc (IRWD) among others .

Click here to see the complete history of Douglas E Williams’s form 4 insider trades.

Insider Ownership Summary of Douglas E Williams

Ticker Comapny Transaction Date Type of Owner
CDAKQ Codiak BioSciences Inc 2023-03-28 director & President & CEO
OVID Ovid Therapeutics Inc 2018-08-14 director
IRWD Ironwood Pharmaceuticals Inc 2014-06-03 director
RGLS Regulus Therapeutics Inc 2012-11-05 director
BIIB Biogen Inc 2015-06-19 EVP Research & Development
CASC Cascadian Therapeutics Inc 2013-06-13 director
SGEN Seagen Inc 2003-09-30 director & CSO & EVP R&D
PANA Panacea Acquisition Corp II 2021-04-06 director
SANA Sana Biotechnology Inc 2023-04-10 EVP & President & R&D

Douglas E Williams Latest Holdings Summary

Douglas E Williams currently owns a total of 3 stocks. Among these stocks, Douglas E Williams owns 11,817 shares of Biogen Inc (BIIB) as of June 19, 2015, with a value of $2 Million and a weighting of 99.34%. Douglas E Williams owns 5,000 shares of Ovid Therapeutics Inc (OVID) as of August 14, 2018, with a value of $15,750 and a weighting of 0.66%. Douglas E Williams also owns 7,655 shares of Codiak BioSciences Inc (CDAKQ) as of March 28, 2023, with a value of $12 and a weighting of 0%.

Latest Holdings of Douglas E Williams

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
BIIB Biogen Inc 2015-06-19 11,817 201.99 2,386,916
OVID Ovid Therapeutics Inc 2018-08-14 5,000 3.15 15,750
CDAKQ Codiak BioSciences Inc 2023-03-28 7,655 0.00 12

Holding Weightings of Douglas E Williams


Douglas E Williams Form 4 Trading Tracker

According to the SEC Form 4 filings, Douglas E Williams has made a total of 0 transactions in Biogen Inc (BIIB) over the past 5 years. The most-recent trade in Biogen Inc is the sale of 3,841 shares on June 19, 2015, which brought Douglas E Williams around $2 Million.

According to the SEC Form 4 filings, Douglas E Williams has made a total of 0 transactions in Ovid Therapeutics Inc (OVID) over the past 5 years. The most-recent trade in Ovid Therapeutics Inc is the acquisition of 5,000 shares on August 14, 2018, which cost Douglas E Williams around $32,450.

According to the SEC Form 4 filings, Douglas E Williams has made a total of 3 transactions in Codiak BioSciences Inc (CDAKQ) over the past 5 years, including 0 buys and 3 sells. The most-recent trade in Codiak BioSciences Inc is the sale of 41,667 shares on March 28, 2023, which brought Douglas E Williams around $7,500.

Insider Trading History of Douglas E Williams

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Douglas E Williams Trading Performance

GuruFocus tracks the stock performance after each of Douglas E Williams's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Douglas E Williams is -30.38%. GuruFocus also compares Douglas E Williams's trading performance to market benchmark return within the same time period. The performance of stocks bought by Douglas E Williams within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Douglas E Williams's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Douglas E Williams

Average Return

Outperforming Transactions

Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -11.6 -30.38 -64.89 -71.45 7 -14.88
Relative Return to S&P 500(%) -13.89 -25.51 -61.57 -71.47 -1.97 -31.19

Douglas E Williams Ownership Network

Ownership Network List of Douglas E Williams

No Data

Ownership Network Relation of Douglas E Williams


Douglas E Williams Owned Company Details

What does Codiak BioSciences Inc do?

Who are the key executives at Codiak BioSciences Inc?

Douglas E Williams is the director & President & CEO of Codiak BioSciences Inc. Other key executives at Codiak BioSciences Inc include See Remarks Yalonda Howze , Chief Scientific Officer Sriram Sathyanarayanan , and See Remarks Nicole Barna .

Codiak BioSciences Inc (CDAKQ) Insider Trades Summary

Over the past 18 months, Douglas E Williams made 3 insider transaction in Codiak BioSciences Inc (CDAKQ) with a net sale of 61,535. Other recent insider transactions involving Codiak BioSciences Inc (CDAKQ) include a net sale of 20,226 shares made by Linda Bain , a net sale of 17,534 shares made by Sriram Sathyanarayanan , and a net sale of 13,132 shares made by Konstantin Konstantinov .

In summary, during the past 3 months, insiders sold 0 shares of Codiak BioSciences Inc (CDAKQ) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 129,081 shares of Codiak BioSciences Inc (CDAKQ) were sold and 0 shares were bought by its insiders, resulting in a net sale of 129,081 shares.

Codiak BioSciences Inc (CDAKQ)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Codiak BioSciences Inc Insider Transactions

No Available Data

Douglas E Williams Mailing Address

Above is the net worth, insider trading, and ownership report for Douglas E Williams. You might contact Douglas E Williams via mailing address: C/o Amgen Inc, One Amgen Center Dr, Thousand Oaks Ca 91320-1799.

Discussions on Douglas E Williams

No discussions yet.